|
H10: the fda rn number for the mdr 2020394-2021-00816 was inadvertently submitted as 2020394.The correct fda rn number was 1018233.H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the bard brachytherapy needle was returned for evaluation.The components received included cannulas, stylets, with needle protectors; the stylets were returned inserted within the cannulas.The packaging appeared to be open at the proximal end.The device components appeared unaffected.Based on the findings, the investigation is confirmed for the reported packaging issue as the it was noted that the packaging was opened in conditions.A definitive root cause for the reported packaging issue could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiry date: 02/2023).H11: section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|